nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0851	0.389	CbGbCtD
Methotrimeprazine—CYP1A2—Leflunomide—systemic scleroderma	0.0812	0.371	CbGbCtD
Methotrimeprazine—CYP2D6—Captopril—systemic scleroderma	0.0525	0.24	CbGbCtD
Methotrimeprazine—Liver injury—Captopril—systemic scleroderma	0.0277	0.0372	CcSEcCtD
Methotrimeprazine—Drug interaction—Captopril—systemic scleroderma	0.0251	0.0337	CcSEcCtD
Methotrimeprazine—Liver injury—Azathioprine—systemic scleroderma	0.0241	0.0325	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Captopril—systemic scleroderma	0.0233	0.0313	CcSEcCtD
Methotrimeprazine—Liver injury—Leflunomide—systemic scleroderma	0.0228	0.0307	CcSEcCtD
Methotrimeprazine—Liver injury—Mycophenolic acid—systemic scleroderma	0.0218	0.0293	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Azathioprine—systemic scleroderma	0.0203	0.0273	CcSEcCtD
Methotrimeprazine—Photosensitivity—Captopril—systemic scleroderma	0.0192	0.0259	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Leflunomide—systemic scleroderma	0.0192	0.0258	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Mycophenolic acid—systemic scleroderma	0.0183	0.0246	CcSEcCtD
Methotrimeprazine—Drug interaction—Lisinopril—systemic scleroderma	0.0178	0.0239	CcSEcCtD
Methotrimeprazine—Drowsiness—Pentoxifylline—systemic scleroderma	0.0172	0.0231	CcSEcCtD
Methotrimeprazine—Liver injury—Mycophenolate mofetil—systemic scleroderma	0.0172	0.0231	CcSEcCtD
Methotrimeprazine—Jaundice—Pentoxifylline—systemic scleroderma	0.0167	0.0225	CcSEcCtD
Methotrimeprazine—Sudden death—Methotrexate—systemic scleroderma	0.016	0.0215	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Captopril—systemic scleroderma	0.0154	0.0208	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Mycophenolate mofetil—systemic scleroderma	0.0144	0.0194	CcSEcCtD
Methotrimeprazine—Photosensitivity—Lisinopril—systemic scleroderma	0.0136	0.0183	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Captopril—systemic scleroderma	0.0133	0.0179	CcSEcCtD
Methotrimeprazine—Jaundice—Captopril—systemic scleroderma	0.0127	0.0171	CcSEcCtD
Methotrimeprazine—Urinary retention—Mycophenolic acid—systemic scleroderma	0.0126	0.017	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Captopril—systemic scleroderma	0.0122	0.0163	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.0121	0.0163	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.0109	0.0147	CcSEcCtD
Methotrimeprazine—Tachycardia—Pentoxifylline—systemic scleroderma	0.0107	0.0144	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Azathioprine—systemic scleroderma	0.0106	0.0143	CcSEcCtD
Methotrimeprazine—Jaundice—Leflunomide—systemic scleroderma	0.0105	0.0141	CcSEcCtD
Methotrimeprazine—Weight increased—Mycophenolic acid—systemic scleroderma	0.0105	0.0141	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.01	0.0135	CcSEcCtD
Methotrimeprazine—Jaundice—Mycophenolic acid—systemic scleroderma	0.00998	0.0134	CcSEcCtD
Methotrimeprazine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00997	0.0134	CcSEcCtD
Methotrimeprazine—Somnolence—Pentoxifylline—systemic scleroderma	0.00974	0.0131	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00958	0.0129	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00956	0.0128	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00944	0.0127	CcSEcCtD
Methotrimeprazine—Weight increased—Lisinopril—systemic scleroderma	0.00941	0.0127	CcSEcCtD
Methotrimeprazine—Constipation—Pentoxifylline—systemic scleroderma	0.00937	0.0126	CcSEcCtD
Methotrimeprazine—Jaundice—Lisinopril—systemic scleroderma	0.00899	0.0121	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00861	0.0116	CcSEcCtD
Methotrimeprazine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00825	0.0111	CcSEcCtD
Methotrimeprazine—Tachycardia—Captopril—systemic scleroderma	0.00811	0.0109	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00807	0.0109	CcSEcCtD
Methotrimeprazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00788	0.0106	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00754	0.0101	CcSEcCtD
Methotrimeprazine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0074	0.197	CbGeAlD
Methotrimeprazine—Somnolence—Captopril—systemic scleroderma	0.00738	0.00993	CcSEcCtD
Methotrimeprazine—Constipation—Captopril—systemic scleroderma	0.0071	0.00955	CcSEcCtD
Methotrimeprazine—Photosensitivity—Methotrexate—systemic scleroderma	0.00677	0.0091	CcSEcCtD
Methotrimeprazine—Tachycardia—Leflunomide—systemic scleroderma	0.00668	0.00898	CcSEcCtD
Methotrimeprazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00637	0.00857	CcSEcCtD
Methotrimeprazine—Constipation—Leflunomide—systemic scleroderma	0.00585	0.00787	CcSEcCtD
Methotrimeprazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00581	0.00781	CcSEcCtD
Methotrimeprazine—Tachycardia—Lisinopril—systemic scleroderma	0.00574	0.00772	CcSEcCtD
Methotrimeprazine—Weight increased—Prednisone—systemic scleroderma	0.00559	0.00752	CcSEcCtD
Methotrimeprazine—Constipation—Mycophenolic acid—systemic scleroderma	0.00558	0.00751	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00534	0.00718	CcSEcCtD
Methotrimeprazine—HTR2A—pulmonary artery—systemic scleroderma	0.00524	0.14	CbGeAlD
Methotrimeprazine—Somnolence—Lisinopril—systemic scleroderma	0.00523	0.00703	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00504	0.00678	CcSEcCtD
Methotrimeprazine—Constipation—Lisinopril—systemic scleroderma	0.00503	0.00676	CcSEcCtD
Methotrimeprazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00503	0.00676	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00469	0.0063	CcSEcCtD
Methotrimeprazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00458	0.00616	CcSEcCtD
Methotrimeprazine—Drowsiness—Methotrexate—systemic scleroderma	0.00458	0.00616	CcSEcCtD
Methotrimeprazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00441	0.00593	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00433	0.00583	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00427	0.00574	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.0038	0.00511	CcSEcCtD
Methotrimeprazine—Tachycardia—Prednisone—systemic scleroderma	0.00341	0.00458	CcSEcCtD
Methotrimeprazine—Constipation—Prednisone—systemic scleroderma	0.00299	0.00402	CcSEcCtD
Methotrimeprazine—Somnolence—Methotrexate—systemic scleroderma	0.0026	0.00349	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Prednisone—systemic scleroderma	0.00257	0.00346	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00215	0.00289	CcSEcCtD
Methotrimeprazine—CHRM5—skin of body—systemic scleroderma	0.00211	0.0563	CbGeAlD
Methotrimeprazine—HTR2A—artery—systemic scleroderma	0.00194	0.0518	CbGeAlD
Methotrimeprazine—HTR2A—endothelium—systemic scleroderma	0.00164	0.0438	CbGeAlD
Methotrimeprazine—HTR2A—blood vessel—systemic scleroderma	0.00151	0.0404	CbGeAlD
Methotrimeprazine—CHRM3—smooth muscle tissue—systemic scleroderma	0.0012	0.0319	CbGeAlD
Methotrimeprazine—CHRM3—digestive system—systemic scleroderma	0.000944	0.0252	CbGeAlD
Methotrimeprazine—HRH1—connective tissue—systemic scleroderma	0.000929	0.0248	CbGeAlD
Methotrimeprazine—ADRA2A—connective tissue—systemic scleroderma	0.000913	0.0244	CbGeAlD
Methotrimeprazine—CHRM1—lung—systemic scleroderma	0.000881	0.0235	CbGeAlD
Methotrimeprazine—HRH1—smooth muscle tissue—systemic scleroderma	0.00085	0.0227	CbGeAlD
Methotrimeprazine—ADRA2C—tendon—systemic scleroderma	0.000786	0.021	CbGeAlD
Methotrimeprazine—HTR2A—connective tissue—systemic scleroderma	0.000776	0.0207	CbGeAlD
Methotrimeprazine—CYP1A2—digestive system—systemic scleroderma	0.000717	0.0191	CbGeAlD
Methotrimeprazine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00071	0.0189	CbGeAlD
Methotrimeprazine—DRD2—lung—systemic scleroderma	0.00071	0.0189	CbGeAlD
Methotrimeprazine—ADRA2C—lung—systemic scleroderma	0.00069	0.0184	CbGeAlD
Methotrimeprazine—HRH1—digestive system—systemic scleroderma	0.000671	0.0179	CbGeAlD
Methotrimeprazine—CYP2E1—digestive system—systemic scleroderma	0.000645	0.0172	CbGeAlD
Methotrimeprazine—HRH1—tendon—systemic scleroderma	0.000639	0.017	CbGeAlD
Methotrimeprazine—ADRA2A—tendon—systemic scleroderma	0.000627	0.0167	CbGeAlD
Methotrimeprazine—CYP2E1—tendon—systemic scleroderma	0.000614	0.0164	CbGeAlD
Methotrimeprazine—CYP1A2—lung—systemic scleroderma	0.000599	0.016	CbGeAlD
Methotrimeprazine—HTR2A—digestive system—systemic scleroderma	0.00056	0.015	CbGeAlD
Methotrimeprazine—HRH1—lung—systemic scleroderma	0.00056	0.015	CbGeAlD
Methotrimeprazine—ADRA2A—lung—systemic scleroderma	0.00055	0.0147	CbGeAlD
Methotrimeprazine—CYP2E1—lung—systemic scleroderma	0.000539	0.0144	CbGeAlD
Methotrimeprazine—HTR2A—tendon—systemic scleroderma	0.000533	0.0142	CbGeAlD
Methotrimeprazine—CYP2D6—digestive system—systemic scleroderma	0.000511	0.0136	CbGeAlD
Methotrimeprazine—HTR2A—lung—systemic scleroderma	0.000468	0.0125	CbGeAlD
